Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Steven K. Feske, M.D.

Co-Author

This page shows the publications co-authored by Steven Feske and Mark Etherton.
Connection Strength

0.563
  1. Etherton MR, Wu O, Cougo P, Lorenzano S, Li H, Cloonan L, Bouts MJRJ, Lauer A, Arai K, Lo EH, Feske SK, Furie KL, Rost NS. Sex-specific differences in white matter microvascular integrity after ischaemic stroke. Stroke Vasc Neurol. 2019 Dec; 4(4):198-205.
    View in: PubMed
    Score: 0.230
  2. Gupta A, Etherton MR, McKee K, Baker JM, Izzy S, Feske SK. Clinical Reasoning: A 68-year-old man with a history of lung cancer presenting with right-sided weakness and aphasia. Neurology. 2015 Oct 06; 85(14):e104-7.
    View in: PubMed
    Score: 0.175
  3. Sharma R, Zachrison KS, Viswanathan A, Matiello M, Estrada J, Anderson CD, Etherton M, Silverman S, Rost NS, Feske SK, Schwamm LH. Trends in Telestroke Care Delivery: A 15-Year Experience of an Academic Hub and Its Network of Spokes. Circ Cardiovasc Qual Outcomes. 2020 03; 13(3):e005903.
    View in: PubMed
    Score: 0.059
  4. Snider S, Stojanovic K, Donnelly D, Etherton M, Feske SK, Izzy S. Clinical Problem-Solving: Lethargy and Fever in an Immunocompromised Patient. Neurohospitalist. 2018 Jan; 8(1):38-41.
    View in: PubMed
    Score: 0.050
  5. Rost NS, Cougo P, Lorenzano S, Li H, Cloonan L, Bouts MJ, Lauer A, Etherton MR, Karadeli HH, Musolino PL, Copen WA, Arai K, Lo EH, Feske SK, Furie KL, Wu O. Diffuse microvascular dysfunction and loss of white matter integrity predict poor outcomes in patients with acute ischemic stroke. J Cereb Blood Flow Metab. 2018 01; 38(1):75-86.
    View in: PubMed
    Score: 0.049
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.